Brainstorm Cell Therapeutics, Inc. (BCLI)
0.9302
-0.07
(-6.98%)
USD |
OTCM |
Oct 02, 16:00
Brainstorm Cell Therapeutics Market Cap : 10.26M for Oct. 2, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 02, 2026 | 10.26M |
| October 01, 2026 | 11.03M |
| September 30, 2026 | 10.48M |
| September 29, 2026 | 10.15M |
| September 28, 2026 | 10.33M |
| September 25, 2026 | 10.70M |
| September 24, 2026 | 10.48M |
| September 23, 2026 | 9.601M |
| September 22, 2026 | 10.41M |
| September 21, 2026 | 9.600M |
| September 18, 2026 | 9.931M |
| September 17, 2026 | 10.81M |
| September 16, 2026 | 10.80M |
| September 15, 2026 | 11.48M |
| September 14, 2026 | 11.73M |
| September 11, 2026 | 11.92M |
| September 10, 2026 | 11.37M |
| September 09, 2026 | 11.03M |
| September 08, 2026 | 10.92M |
| September 04, 2026 | 11.59M |
| September 03, 2026 | 11.81M |
| September 02, 2026 | 13.79M |
| September 01, 2026 | 12.88M |
| August 31, 2026 | 11.75M |
| August 28, 2026 | 12.40M |
| Date | Value |
|---|---|
| August 27, 2026 | 12.83M |
| August 26, 2026 | 13.24M |
| August 25, 2026 | 11.03M |
| August 24, 2026 | 11.03M |
| August 21, 2026 | 10.81M |
| August 20, 2026 | 11.70M |
| August 19, 2026 | 13.43M |
| August 18, 2026 | 15.56M |
| August 17, 2026 | 11.98M |
| August 14, 2026 | 10.92M |
| August 13, 2026 | 9.004M |
| August 12, 2026 | 9.573M |
| August 11, 2026 | 9.380M |
| August 10, 2026 | 8.718M |
| August 07, 2026 | 8.690M |
| August 06, 2026 | 8.828M |
| August 05, 2026 | 8.562M |
| August 04, 2026 | 8.524M |
| August 03, 2026 | 8.718M |
| July 31, 2026 | 9.931M |
| July 30, 2026 | 10.13M |
| July 29, 2026 | 9.883M |
| July 28, 2026 | 10.15M |
| July 27, 2026 | 10.31M |
| July 24, 2026 | 10.59M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| NovelStem International Corp. | 0.4687M |
| Summit Therapeutics, Inc. | 13.29B |
| Kezar Life Sciences, Inc. | 53.76M |
| Protara Therapeutics, Inc. | 159.53M |
| Clene, Inc. | 52.14M |
Market Cap Related Metrics
| Price | 0.9302 |
| Earnings Yield | -102.6% |